Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hospira To Acquire API, R&D Facilities | Contract Pharma
Breaking News

Hospira To Acquire API, R&D Facilities

Gains Aurangabad site from Orchid Chemicals

Hospira, Inc. has entered an agreement to acquire an API manufacturing facility and an associated R&D facility from Orchid Chemicals & Pharmaceuticals Ltd., an Indian pharmaceutical company, for approximately $200 million. With the acquisition, the company aims to reduce costs, support the supply of key antibiotic products and the future development of APIs.
 
The 50,000 square meter facility in Aurangabad employs 640 chemists, engineers and technicians. The R&D facility based in Chennai will be dedicated to beta-lactam and other APIs and has approximately 190 employees. Orchid will retain its cephalosporin API business and facilities, and will continue to supply Hospira with API.
 
“Our decision to acquire Orchid’s world-class API facility demonstrates Hospira’s continued dedication to the antibiotics space, enhancing cost-competitiveness and ensuring continuity of supply,” said Dr. C. Bhaktavatsala Rao, managing director, Hospira India. “This is a top-of-the-line API manufacturing facility that has been recognized by industry leaders for its high standards. We look forward to welcoming our new colleagues from Orchid and leveraging their expertise to continue to bring high quality, lower-cost products to patients around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters